Up­dat­ed: In­di­an man­u­fac­tur­er un­der scruti­ny af­ter cough syrups linked to deaths in West Africa

Maid­en Phar­ma­ceu­ti­cals, an In­dia-based pro­duc­er of sev­er­al gener­ic drugs, came un­der fire re­cent­ly from the WHO as sev­er­al of its cough syrup prod­ucts were linked to the deaths of more than 60 chil­dren in Gam­bia, ac­cord­ing to re­ports.

The WHO last week is­sued an alert over four cough syrup-based prod­ucts: Promet­hazine Oral So­lu­tion, Kofex­ma­lin Ba­by Cough Syrup, Makoff Ba­by Cough Syrup and Ma­grip N Cold Syrup. The WHO alert said there are no safe­ty guar­an­tees, and lab sam­ples con­tain con­t­a­m­i­nants such as di­eth­yl­ene gly­col and eth­yl­ene gly­col, which are chem­i­cals main­ly used in an­tifreeze or brake flu­id.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER